Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | -5.79% | +39.18% | -62.60% |
May. 30 | Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from S&P TMI Index | CI |
May. 27 | Finch Therapeutics Group, Inc.(OTCPK:FNCH) dropped from NASDAQ Composite Index | CI |
Financials (USD)
Sales 2022 | 861K | Sales 2023 | 107K | Capitalization | 5.8M |
---|---|---|---|---|---|
Net income 2022 | -115M | Net income 2023 | -74M | EV / Sales 2022 | 5.01 x |
Net cash position 2022 | 18.68M | Net Debt 2023 | 5M | EV / Sales 2023 | 101 x |
P/E ratio 2022 |
-0.2
x | P/E ratio 2023 |
-0.08
x | Employees | 1 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 46.52% |
1 day | -5.79% | ||
1 week | +39.18% | ||
Current month | +39.61% | ||
1 month | -39.46% | ||
3 months | -45.98% | ||
6 months | -67.70% | ||
Current year | -62.60% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Blischak
CEO | Chief Executive Officer | - | 23-05-15 |
Lance Thibault
DFI | Director of Finance/CFO | 58 | 23-05-15 |
Sonia Timberlake
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Graf
CHM | Chairman | 52 | 21-04-22 |
Jeffery Smisek
BRD | Director/Board Member | 69 | 17-08-31 |
Chris Shumway
BRD | Director/Board Member | 58 | 20-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 1.35 | -5.79% | 9,394 |
24-06-05 | 1.433 | +11.95% | 2,689 |
24-06-04 | 1.28 | -11.72% | 1,316 |
24-06-03 | 1.45 | +49.94% | 24,945 |
24-05-31 | 0.967 | -0.31% | 24,275 |
Delayed Quote OTC Markets, June 06, 2024 at 03:14 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-62.60% | 2.3M | |
+55.55% | 59.34B | |
+43.17% | 40.24B | |
-4.71% | 39.88B | |
-5.56% | 28.55B | |
+13.76% | 27.26B | |
-22.00% | 19.23B | |
+31.50% | 12.61B | |
+2.16% | 12.49B | |
+25.70% | 12.28B |
- Stock Market
- Equities
- FNCH Stock